Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients
Coronavirus
By Vijay Kumar Malesu Reviewed by Lily Ramsey, LLM Oct 30 2024 New research highlights the effectiveness of nirmatrelvir-ritonavir in lowering hospitalization rates and long COVID symptoms in non-hospitalized, high-risk COVID-19 patients. Study: Nirmatrelvir plus ritonavir reduces COVID-19 hospitalization and prevents long COVID in adult outpatients . Image Credit: Simplylove/Shutterstock.com In a recent study published in the Scientific Reports , a group of researchers evaluated the
din zilele anterioare